Introduction {#section5-1178636119890302}
============

Influenza is a common human virus infecting the population during the cold winter months. In particular, the elderly population may suffer from severe and life-threatening disease. Frequently, clinical symptoms are myalgia, headache, fever, and cough, and in the case of influenza B infection, gastrointestinal symptoms.^[@bibr1-1178636119890302]^ The clinical triad of cough, fever, and pain is held to be very indicative for influenza disease during the dedicated season, but they cannot distinguish from those of other viral respiratory tract infections. The absence of that triad cannot exclude influenza infection. Influenza may present as an exacerbation or complication of an underlying illness.^[@bibr2-1178636119890302]^ Data in the literature focus on the elderly population or pediatric patients.^[@bibr3-1178636119890302][@bibr4-1178636119890302][@bibr5-1178636119890302][@bibr6-1178636119890302]-[@bibr7-1178636119890302]^ Most of the patients recover from the illness without needing any intensive medical attention. However, increasing age and fragility due to comorbidities increase the risk of a severe course of influenza infection. Moreover, community outbreaks during the cold winter months can overload emergency departments and hospital units of internal medicine. In hospital, influenza patients need isolated rooms and more resources due to contagiosity of neighboring patients. According to the Robert Koch Institute (RKI) report, during the season 2017/2018, influenza disease caused increased health care visits in Germany to as high as 9 million medical visits, and thus increased by about 2 million (+28%) compared with the severe seasons of 2012/2013 and 2014/2015.^[@bibr8-1178636119890302]^ A total of 68% of the influenza patients were aged above 60 years, and the hospitalization rate was much higher with 69% than in the group of \<60 years with about 31%, too.

Our retrospective analysis was aimed at characterization of the clinical presentation and features of influenza-positive patients admitted to the emergency department of internal medicine of our university hospital in season 2017/2018 according to different age groups.

Materials and Methods {#section6-1178636119890302}
=====================

The retrospective study was performed at our emergency department of internal medicine with about 10 500 adult patients in the year 2017. Patients are admitted by self-motivation, after a visit of a referring outpatient doctor or by ambulance (sometimes with emergency doctor). The local ethics committee approved the retrospective analysis. The study complies with the ethics guidelines of the Helsinki Declaration. Between October 11, 2017, and April 27, 2018, all patients aged above 18 years with a reverse transcription-polymerase chain reaction (RT-PCR)-positive influenza test were included. The reverse transcription-polymerase chain reaction was performed in patients with suspicion of influenza, presenting singular or several symptoms of flu diseases or just for exclusion of influenza disease (question of isolating patients within the care units).

In these 7 months, 723 RT-PCR tests for influenza were performed in the emergency department, 249 (34.4%) of which were positive. Nine patients needed to be excluded due to missing clinical data---these patients were apparently only tested. Children (aged \<18 years) present specifically in the children's hospital and therefore, they were not part of our baseline cohort. The remaining 240 patients were assessed for epidemiological, clinical, laboratory, and radiological profile, as well as outcome (need for and duration of hospitalization and/or death). Patients were grouped according to the circulating influenza subtype A (H1N1 or H3N2) or B and divided into 3 different age groups (\<40 years \[ie 18-39 years\], 40-60 years, and ⩾60 years).

Influenza testing was performed by taking nasal and pharyngeal swabs that were sent to the virology laboratory for RT-PCR testing by Xpert^®^ Xpress Flu/RSV (Cepheid, Sunnyvale, CA, USA). Subtyping of influenza A-positive samples was performed by type-specific in-house PCR assays for the H1pdm2009 and H3 hemagglutinin gene as described previously.^[@bibr9-1178636119890302],[@bibr10-1178636119890302]^ We chose 6 documented risk factors for a severe course or complications of the influenza disease indicating the use of neuraminidase inhibitors: age ⩾ 60 years, chronic obstructive pulmonary disease (COPD), diabetes mellitus, cardiac insufficiency, immunosuppression, or neurologic disorders (previous stroke or ongoing neurologic disease with motor impairment).^[@bibr11-1178636119890302]^ Immunosuppression included immunosuppressant drugs or patients who have received chemotherapy. Conditions such as home nursing, bed confinement, or pregnancy were also evaluated. Documented symptom onset (sudden or not), duration of symptoms before admittance to the emergency department, and documented clinical symptoms such as cough, sputum, fever (including body temperature \>38°C, feverishness \[subjective feeling of fever\], and shivering) as well as headache or myalgia were surveyed. Additional features such as heart rate (per minute), respiratory rate (per minute), systolic blood pressure (mmHg), and O~2~ saturation (%) and such as need for and duration of hospitalization, suspicion of consolidation in a chest X-ray, and initial application of a first dose of a neuraminidase inhibitor (oseltamivir) or of antibiotics were analyzed. Analysis of laboratory investigation at the time of presentation in the emergency department included leukocytes (normal: 4-10 × 10^3^/µL), thrombocytes (normal: 160-400 × 10^3^/µL), and C-reactive protein (normal: \<5 mg/L). The presence of secondary bacterial infection, sometimes observed within the course of disease, was not checked.

For statistical analysis, clinical and laboratory parameters were expressed as mean ± standard deviation together with the range in square brackets. The t-test was used to compare mean values. Results were considered statistically significant for *P* \< .05 and statistically highly significant for *P* \< .001. All reported *P*-values are two-sided. Statistical analysis was performed using the Statistical Package for the Social Sciences (Version 24.0.0.2; IBM Corp, Armonk, NY, USA).

Results {#section7-1178636119890302}
=======

Patients' characteristics {#section8-1178636119890302}
-------------------------

From 723 RT-PCR tests for influenza performed in the emergency department of internal medicine during season 2017/2018, a total of 240 positive tested adult patients (132 females and 108 males, mean age: 65 years) were included in the final analysis. Of which, 168 (70%) patients were diagnosed with influenza B (95 females and 73 males, mean age: 68 years), whereas 72 patients had influenza A (64 \[27%\] H1N1, 6 (3%) H3N2, and 2 without typing possible) with a mean age of 57 years ([Table 1](#table1-1178636119890302){ref-type="table"}). In some cases, data were insufficient or missing or examination not performed (see tables).

###### 

Overall characteristics of the 240 patients with positive influenza RT-PCR testing.

![](10.1177_1178636119890302-table1)

                                       Total                       A            B
  ------------------------------------ --------------------------- ------------ -----------------------------------------------------------------
  No. of patients                      240                         72           168
  Sex (female/male)                    132/108                     37/35        95/73
  Age (years)                          65 ± 18 \[18-94\]           57 ± 19      68 ± 17[\*\*](#table-fn3-1178636119890302){ref-type="table-fn"}
  Systolic blood pressure (mmHg)       140 ± 22 \[73-199\]         138 ± 22     140 ± 22
  Heart rate (per minute)              89 ± 18 \[55-151\]          93 ± 17      87 ± 19[\*](#table-fn3-1178636119890302){ref-type="table-fn"}
  Respiratory rate (per minute)        19 ± 5 \[10-40\]            19 ± 5       20 ± 5
  O~2~ saturation (%)                  95 ± 4.3 \[64-100\]         95.5 ± 3.7   94.6 ± 4.5
  Leukocyte (× 10^3^/µL)               7.13 ± 4.7 \[0.43-37.09\]   7.32 ± 5.1   7.04 ± 4.5
  Thrombocyte (× 10^3^/µL)             191.6 ± 79 \[9-720\]        182.6 ± 59   195.2 ± 86
  CRP (mg/L)                           51 ± 63 \[0.6-360.6\]       60 ± 78      47.3 ± 55
  Sudden onset of symptoms             13 (5%)                     8 (11%)      5 (3%)
  Duration of symptoms (days)          5.2 ± 5.4 \[0.12-42\]       5.0 ± 6.7    5.3 ± 4.7
  No. of symptoms (out of 3)           1.9 ± 1.2                   2.0 ± 1.3    1.8 ± 0.9
  Cough                                200 (83%)                   62 (86%)     138 (82%)
  Headache/myalgia                     90 (38%)                    39 (54%)     57 (34%)
  Fever/shivering                      146 (62%)                   45 (63%)     101 (60%)
  Sputum                               62 (26%)                    14 (19%)     48 (29%)
  No. of risk factors (out of 6)       1.5 ± 1.2 \[0-6\]           1.2 ± 1.2    1.7 ± 1.2[\*](#table-fn3-1178636119890302){ref-type="table-fn"}
  Age ⩾ 60 years                       162 (68%)                   36 (50%)     126 (75%)
  COPD                                 48 (20%)                    11 (15%)     37 (22%)
  Diabetes mellitus                    52 (22%)                    12 (17%)     40 (24%)
  Cardiac insufficiency                27 (11%)                    7 (10%)      20 (12%)
  Immunosuppression                    42 (18%)                    8 (11%)      34 (20%)
  Neurologic disorders                 32 (13%)                    5 (7%)       27 (16%)
  Nursing home/bed confinement         21 (9%)                     3 (4%)       18 (11%)
  Pregnancy                            2 (1%)                      2 (3%)       0
  Suspicion of infiltrate in X-ray     52 (22%)                    19 (26%)     34 (20%)
  First antibiotics                    119 (50%)                   32 (44%)     87 (52%)
  Oseltamivir                          194 (81%)                   56 (78%)     138 (82%)
  Hospitalization                      136 (57%)                   32 (44%)     104 (62%)
  Duration of hospitalization (days)   7.1 ± 4.1 \[1-22\]          7.6 ± 4.9    6.9 ± 3.8
  Mortality                            14 (5.8%)                   5 (7%)       9 (5.4%)

Abbreviations: COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; RT-PCR, reverse transcription-polymerase chain reaction.

Missing data: heart rate (n = 1), respiratory rate (n = 12), O~2~ saturation (n = 1), systolic blood pressure (n = 2), leucocytes/thrombocytes (n = 9), CRP (n = 8), and duration of symptoms (n = 19). Data are represented as mean ± standard deviation \[range\].

\[Range\], \**P* \< .05, \*\**P* \< .001.

Sudden onset of symptoms was documented in only 5.4% of influenza-positive cases and less frequently in influenza B patients. The most frequently documented symptom was cough (83%). Fever (61%), headache/myalgia (31%), and sputum (26%) were observed less frequently. The presence of headache or myalgia was lower in influenza B than in A. Overall, on average, 2 documented symptoms out of the 3 main symptoms were presented with a mean symptom duration of 5.2 days before admission to the emergency department. Analyses of the average number of the documented symptoms (out of 3) presented in the emergency department ([Table 2](#table2-1178636119890302){ref-type="table"}) showed that, on average, 2.7 symptoms were presented in the first group \<40 years, as opposed to 1.6 of the patients aged ⩾60 years (*P* = .0001, [Figure 1](#fig1-1178636119890302){ref-type="fig"}). Documented duration of symptoms was shorter in the group of \<40 years. Younger patients went often self-motivated to the emergency department (65%), elderly rarely (19%, [Table 2](#table2-1178636119890302){ref-type="table"}).

###### 

Symptomatic appearance of influenza illness according to age groups.

![](10.1177_1178636119890302-table2)

  ---------------------------------------------------------------------------------------------------------------------------------------------------
                                  \<40 years\         40-59 years\        ⩾60 years\
                                  (n = 30)            (n = 48)            (n = 162)
  ------------------------------- ------------------- ------------------- ---------------------------------------------------------------------------
  Duration of symptoms (days)     3.3 ± 2.9           5.4 ± 7.8           5.5 ± 4.8[\*](#table-fn5-1178636119890302){ref-type="table-fn"}

  No. of symptoms (out of 3)      2.7 ± 0.5 \[2-3\]   2.0 ± 1.0 \[0-3\]   1.6 ± 0.8 \[0-3\][\*\*](#table-fn5-1178636119890302){ref-type="table-fn"}

   0                              0                   5 (10.4%)           12 (7.4%)

   1                              0                   8 (16.7%)           58 (36%)

   2                              9 (30%)             18 (37.5%)          68 (42%)

   3                              21 (70%)            17 (35.4%)          24 (15%)

  Cough                           28 (93%)            38 (79%)            134 (83%)

  Fever/shivering                 28 (93%)            32 (67%)            86 (53%)

  Headache/myalgia                25 (83%)            25 (52%)            45 (28%)

  Emergency admission by                                                  

   Self-motivation                19 (65%)            25 (58%)            29 (19%)

   Referring outpatient doctor    4 (14%)             8 (18.5%)           31 (20%)

   Ambulance                      6 (21%)             8 (18.5%)           75 (49%)

   Preclinical emergency doctor   0                   2 (5%)              18 (12%)
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Missing data: type of emergency admission (n = 15).

\[Range\], \**P* \< .05, \*\**P* \< .001.

![Symptoms (cough, fever, or headache/myalgia) presented by influenza patients (n = 240) according to age groups.](10.1177_1178636119890302-fig1){#fig1-1178636119890302}

Risk factors, in general, describe the individual condition of a person that makes him or her more affectable for a disease or for a more severe course of it. The analysis of the 6 main risk factors ([Table 3](#table3-1178636119890302){ref-type="table"}) showed age to be the most frequent risk factor, followed by diabetes mellitus, COPD, and immunosuppression. The oldest group (⩾60 years) has highly significantly more documented risk factors and consequently, a higher hospitalization rate with a longer duration than the younger groups. Patients with influenza B had more risk factors than patients with influenza A (*P* = .0023). Patients aged \<40 years had fewer risk factors than the other, older patient groups ([Figure 2](#fig2-1178636119890302){ref-type="fig"}). About one-fourth of the elderly patients showed no additional dedicated and documented risk factor except advanced age (⩾60 years). Patients with immunosuppression (n = 42) showed significantly fewer documented main symptoms (mean number: 1.8) than patients without immunosuppression (mean number: 2.2, *P* = .042). The subanalysis of the remaining 198 patients (without immunosuppression) showed fewer documented symptoms with increasing age as it was shown in all patients. Overall, 57% of the influenza patients were cared for in hospital. The average duration of hospitalization overall was 7.1 ± 4.1 days \[1-22\], without a statistically significant difference between influenza A and B patients (7.6 versus 6.9 days, respectively). Rate and duration of hospitalization were higher in the elderly group (⩾60 years; [Figure 3](#fig3-1178636119890302){ref-type="fig"}). Patient age, the average number of risk factors, and the respiratory rate among patients hospitalized were significantly higher than those who left the emergency department in an outpatient setting (*P* \< .0001, *P* = .001, and *P* \< .0001, respectively).

###### 

Number of risk factors (age, COPD, cardiac insufficiency, diabetes mellitus, neurologic disorders, or immunosuppression) and hospitalization according to age groups.

![](10.1177_1178636119890302-table3)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
                                       \<40 years\          40-59 years\         ⩾60 years\
                                       (n = 30)             (n = 48)             (n = 162)
  ------------------------------------ -------------------- -------------------- --------------------------------------------------------------------------
  Risk factors                         0.3 ± 0.7 \[0-3\]    0.4 ± 0.7            2.1 ± 1 \[1-6\][\*\*](#table-fn7-1178636119890302){ref-type="table-fn"}

   0                                   21 (72%)             31 (65%)             0

   1-2                                 8 (25%)              16 (33%)             114 (70%)

   3-4                                 1 (3%)               1 (2%)               43 (27%)

   5-6                                 0                    0                    5 (3%)

  Suspicion of infiltrate in X-ray     2 (7%)               6 (13%)              45 (28%)

  Antibiotics                          4 (13%)              16 (34%)             99 (61%)

  Outpatient                           23 (77%)             31 (65%)             50 (31%)

  Hospitalization                      7 (23%)              17 (35%)             112 (69%)

  Mean duration                        7.4 ± 7.6 \[1-22\]   5.1 ± 2.5 \[1-10\]   7.2 ± 4 \[1-19\][\*\*](#table-fn7-1178636119890302){ref-type="table-fn"}

  Duration of hospitalization (days)                                             

   1-3                                 3 (43%)              4 (24%)              21 (19%)

   4-7                                 1 (14%)              9 (52%)              44 (39%)

   8-10                                1 (14%)              4 (24%)              30 (27%)

   \>10                                2 (29%)              0                    17 (15%)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviation: COPD, chronic obstructive pulmonary disease.

\[Range\], \*\**P* \< .001.

![Risk factors (age, COPD, cardiac insufficiency, diabetes mellitus, neurologic disorders, or immunosuppression) presented by influenza patients (n = 240) according to age groups. COPD indicates chronic obstructive pulmonary disease.](10.1177_1178636119890302-fig2){#fig2-1178636119890302}

![Duration of hospitalization of n = 134 (57%) of all influenza patients according to age groups.](10.1177_1178636119890302-fig3){#fig3-1178636119890302}

A possible infiltrate in a chest X-ray was suspected in 22%. Initial treatment included antibiotics in 50% and a neuraminidase inhibitor (oseltamivir) in 81%. Out of our 240 analyzed patients, a total of n = 14 (5.8%) died during hospitalization. Of them, 2 patients were \<60 years (mortality: 2.6%) and 12 patients were ⩾60 years (mortality: 7.4%, [Table 4](#table4-1178636119890302){ref-type="table"}); 5 had influenza A (mortality: 7%) and 9 suffered from influenza B (mortality: 5.4%). These patients died mostly (83%) within 7 days after admission and showed in average only 1 out of 3 typical symptoms. Moreover, the number of risk factors documented was in average 3 including the age and thus was higher than that of the survivors ([Table 4](#table4-1178636119890302){ref-type="table"}).

###### 

Characteristics of influenza patients with mortality aged ⩾60 years (n = 12).

![](10.1177_1178636119890302-table4)

                                       Elderly with mortality   Elderly hospitalized survivors
  ------------------------------------ ------------------------ ------------------------------------------------------------------
  Age ⩾60 years                        12 (100%)                100 (100%)
  Mean age (years)                     76.6 ± 6                 77 ± 8
  Respiratory rate (per minute)        22 ± 6 \[15-36\]         21 ± 6 \[13-40\]
  Heart rate (per minute)              89 ± 22 \[59-126\]       89 ± 19 \[55-140\]
  Systolic blood pressure (mmHg)       134.8 ± 24 \[95-176\]    142 ± 24 \[73-199\]
  Duration of symptoms (days)          4.8 ± 3.3                6 ± 5.4
  No. of symptoms (out of 3)           1.0 ± 1                  1.54 ± 0.8[\*](#table-fn8-1178636119890302){ref-type="table-fn"}
  Cough                                7 (58%)                  83 (83%)
  Fever/feverishness                   3 (25%)                  52 (52%)
  Headache/myalgia                     2 (17%)                  18 (18%)
  No. of risk factors (out of 6)       3.1 ± 1 \[1-5\]          2.1 ± 1[\*\*](#table-fn8-1178636119890302){ref-type="table-fn"}
  Duration of hospitalization (days)                            
   1-3                                 3 (25%)                  18 (18%)
   4-7                                 7 (58%)                  37 (37%)
   8-10                                0                        30 (30%)
   \>10                                2 (17%)                  15 (15%)

\[Range\], \**P* \< .05, \*\**P* \< .001.

Discussion {#section9-1178636119890302}
==========

Pronounced incidence of influenza disease during winter months is generally due to influenza A in up to 85% of cases.^[@bibr8-1178636119890302],[@bibr12-1178636119890302]^ In winter 2017/2018, RT-PCR-positive tested adult patients (⩾18 years) in our emergency department had mainly influenza B (70%) compared with influenza A (30%). In our retrospective analysis of all influenza cases at our emergency department, sudden onset of symptoms was rarely documented (5.4%). Symptoms had been present for 5 days on average before presentation at the emergency department. In other studies, influenza patients with complaints longer than 3 or 7 days were excluded.^[@bibr1-1178636119890302],[@bibr13-1178636119890302],[@bibr14-1178636119890302]^ Neuraminidase inhibitors may alleviate the course of the disease, particularly if administered within 48 hours of onset. We started treatment directly in our emergency department in 81% of patients. In similar settings, oseltamivir is administered in up to 88.7%, also after a delayed admission.^[@bibr2-1178636119890302],[@bibr12-1178636119890302],[@bibr13-1178636119890302]^ The effectiveness of oseltamivir may be questioned. We started the first dose of oseltamivir immediately in case of suspicion of influenza disease and risk of severe course in the emergency department. Considering a positive rate of influenza testing of about 1/3, a relevant proportion of patients were treated without having an influenza illness. We justify this procedure given the low side effects of oseltamivir after one first dose, the relevant mortality of influenza, and being at an emergency department with high incidence of influenza. Moreover, this retrospective study was limited to RT-PCR-positive influenza cases, and some patients admitted to the emergency department may have had health complications exacerbated by a waning influenza infection which could not be detected by RT-PCR.

Patients aged above 60 years showed more documented risk factors, presented with milder or missing typical symptoms, had been suffering from symptoms a longer time before admission, and were hospitalized more often and longer than younger patients (\<60 and \<40 years). Patients with influenza (\<60 years) presented mainly (61%) self-motivated without contacting an outpatient doctor, whereas 49% of patients aged ⩾60 years were admitted by ambulance. In addition, our data show cough and fever to be the most important documented symptoms of influenza disease,^[@bibr15-1178636119890302]^ although the complete triad of cough, fever, and myalgia was only present in 26%. In the literature, the cluster of fever, cough, and sore throat occurs in only 31% of influenza cases.^[@bibr4-1178636119890302]^

A clinical diagnosis algorithm---based on the presence of all 3 traditional symptoms---for the detection of influenza in the elderly in the cold months should be used restrictively, since 68% of our influenza cases were elderly people (⩾60 years) showing fewer or milder documented symptoms in comparison with younger patients \<60 or \<40 years.

Choi et al^[@bibr13-1178636119890302]^ conducted a retrospective, multicenter study of 1405 influenza-positive patients who were predominantly young with 42.9 years. The hospitalization rate was 21% and mortality 3.1% and were therefore lower than in our cohort. Fever and cough were the most frequent signs of influenza. Mean age of patients, rate of influenza B, and hospitalization rate (28.9%) were higher in case of a late diagnosis of influenza disease (diagnosis 4-7 days after symptom onset). According to our data, influenza B was predominant with high patient ages and also with a late diagnosis. N = 53 (22%) of all influenza patients presented no risk factors allowing for outpatient care (n = 38, 72%) or a short duration hospitalization (⩽3 days). Influenza disease might deteriorate concomitant diseases, and anticipating course of disease is difficult, leading to a high hospitalization rate of the elderly. Besides age, diabetes, COPD, and immunosuppression were the most common risk factors in our cohort. In literature, the incidence of comorbidities in influenza disease is reported to be for up to 76%, with mainly arterial hypertension or diabetes.^[@bibr2-1178636119890302],[@bibr4-1178636119890302],[@bibr12-1178636119890302],[@bibr15-1178636119890302]^

In our cohort, duration of hospitalization was about 7 days and mortality 5.8%. Data of 65 influenza A patients showed a mortality of 15.4% during a mean of 6.3 days of hospitalization^[@bibr15-1178636119890302]^; 61.5% had a suspicion of pneumonic infiltrates upon chest X-ray in contrast to 22% in our study. In another study, 1726 hospitalized patients (mean age: 64 years) stayed in hospital for on average 14.8 days and had a mortality of 13%.^[@bibr12-1178636119890302]^ Age and immune deficiency (mainly in type B influenza) were associated with mortality. Our patients with immunosuppression (n = 42) had also predominantly influenza B and showed significantly fewer documented symptoms. Our analysis of the lethal courses of influenza infection indicates that the sum of documented risk factors seems to predict mortality as in contrast, the presenting complex of symptoms cannot. Due to the plurality of patients, establishing a precise prognosis tends to be difficult.^[@bibr16-1178636119890302]^ Figures from these different studies may be difficult to interpret because there are differences in geographic location (Asia^[@bibr1-1178636119890302],[@bibr15-1178636119890302]^ versus North America)^[@bibr4-1178636119890302]^, circumstances (outpatient^[@bibr2-1178636119890302]^ versus hospital)^[@bibr12-1178636119890302]^, patient age (rather young^[@bibr13-1178636119890302]^ versus old),^[@bibr4-1178636119890302],[@bibr12-1178636119890302]^ and type of influenza (A or B).

The power of our findings is limited by certain weaknesses, for example, the retrospective nature of the study. Details of the medical history may be lost in contrast to a standardized, prospective approach. Another drawback might be the fact that the sample size was quite small. Nevertheless, tendencies and statistically significant findings could be shown. Information concerning preceding visits or outpatient contacts before admission to the emergency department was not available. We have no details on influenza vaccination of our patients. Observed characteristics of influenza infection may vary depending on the setting. We showed an evaluation in an emergency department of internal medicine dealing with selected outpatient and pre-hospitalized patients. In an outpatient setting or a common general emergency center, the question of influenza relies more easily on clinical symptoms or may be less frequent. Nevertheless, our observations empower emergency physicians to think of influenza disease more often in their decision-making process for testing and administering antivirals.^[@bibr17-1178636119890302],[@bibr18-1178636119890302]^

In conclusion, at an emergency department, influenza-diseased patients are of higher age and show an increased number of comorbidities and quite rarely the typical symptoms. Elderly patients with influenza are more likely to have milder symptoms and have a high hospitalization rate with a longer hospital stay as compared with younger patients. The observed delay of diagnosis should lead to an earlier contact to health care and proof of influenza by RT-PCR testing, particularly in elderly patients with risk factors, even without having all typical symptoms.
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